Welcome to GENESIS Hangzhou!

page_banner

product

Factory source Rapid Antigen Nasal Swab Test - KaiBiLi COVID-19 Antigen -saliva swab – Genesis


Product Detail

Related Video

Feedback (2)

We keep on with the basic principle of "quality to start with, support very first, continuous improvement and innovation to meet the customers" for your management and "zero defect, zero complaints" as the quality objective. To great our service, we offer the items with all the superior top quality at the reasonable selling price for Test Rapid Test Antigen, Rapid Antigen Test Saliva, Rapid Antigen Swab Antigen, We are looking forward to establishing long-term business relationships with you. Your comments and suggestions are highly appreciated.
Factory source Rapid Antigen Nasal Swab Test - KaiBiLi COVID-19 Antigen -saliva swab – Genesis Detail:

Introduction

SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDT) are being used globally to test suspect COVID-19 cases in contexts where PCR diagnostic may not be available, often at subnational level.

COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

Individual factors can contribute to SARS-CoV-2 transmission

● People infected with SARS-CoV-2 can transmit virus with or without symptoms

● Most infected people transmit the virus around 2 days before they develop symptoms and up to 9-10 days after symptom onset

● People who develop severe disease can be infectious for longer

● Immunocompromised people can shed the virus for months

● Symptomatic persons infected with SARS-CoV-2 are 3 to 18 times more likely to transmit the virus than asymptomatic persons.

Detection

The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva.

Specimen

Saliva

Limit of Detection (LoD)

2019 Novel Coronavirus: 74.8 TCID50/mL

Accuracy

Positive Percent Agreement: 96.5%

Negative Percent Agreement:97.8%

Overall Percent Agreement: 97.2%

Time to Results

Read results at 15minutes and no more than 30 minutes.

Kit Storage Conditions

2~30°C.

Contents

Description

Qty

COVID-19 antigen test devices

20

Sterile Swabs (For saliva collection)

20

Extraction tubes (with extraction buffer)

20

Nozzles with filter

20

Tube Stand

1

Package Insert

1

Ordering Information

Product

Cat.No.

Contents

KaiBiLiTM COVID-19 Antigen

P211140-S

20 Tests


Product detail pictures:

Factory source Rapid Antigen Nasal Swab Test - KaiBiLi COVID-19 Antigen -saliva swab – Genesis detail pictures


Related Product Guide:

With our excellent management, strong technical capability and strict quality control system, we continue to provide our clients with reliable quality, reasonable prices and excellent services. We aim at becoming one of your most reliable partners and earning your satisfaction for Factory source Rapid Antigen Nasal Swab Test - KaiBiLi COVID-19 Antigen -saliva swab – Genesis , The product will supply to all over the world, such as: Georgia, Georgia, Russia, Taking the core concept of "to be the Responsible". We'll redound up on society for high quality merchandise and good service. We will initiative to participate in international competition to be a first- class manufacturer of this product in the world.
The factory technical staff not only have high level of technology, their English level is also very good, this is a great help to technology communication.
5 Stars By David from Greek - 2018.09.23 17:37
This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
5 Stars By Rosalind from Uruguay - 2018.02.04 14:13
Write your message here and send it to us